Mannkind (MNKD) Other Non-Current Liabilities (2012 - 2026)
Mannkind's (MNKD) quarterly Other Non-Current Liabilities came in at $5.1 million in Q1 2026, down 96.57% year-on-year from $150.2 million in Q1 2025, and up 0.63% on a QoQ basis from $5.1 million in Q4 2025.
Mannkind (MNKD) Other Non-Current Liabilities (2012 - 2026) Analysis & Trends
Mannkind (MNKD) has 15 years of Other Non-Current Liabilities data on file, last reported at $5.1 million in Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities fell 96.57% year-over-year to $5.1 million in Q1 2026; TTM through Mar 2026 was $5.1 million, a 96.57% decrease from a year earlier, with the FY2025 full-year figure at $5.1 million, down 96.58% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $5.1 million, up from $5.1 million in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for MNKD reached as high as $250.9 million in Q2 2023 and fell as low as $300000.0 in Q1 2024.
- Historically, Other Non-Current Liabilities has averaged $76.5 million across 5 years, with a median of $17.6 million in 2025.
- Across the five-year window, Other Non-Current Liabilities slumped 96.84% in 2022 and soared 49966.67% in 2025, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $600000.0 in 2022, then jumped by 37250.0% to $224.1 million in 2023, then slumped by 33.24% to $149.6 million in 2024, then slumped by 96.58% to $5.1 million in 2025, then grew by 0.63% to $5.1 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $5.1 million in Q1 2026, $5.1 million in Q4 2025, and $17.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.15 Mn |
| Dec 31, 2025 | 5.11 Mn |
| Sep 30, 2025 | 17.60 Mn |
| Jun 30, 2025 | 36.20 Mn |
| Mar 31, 2025 | 150.20 Mn |
| Dec 31, 2024 | 149.60 Mn |
| Sep 30, 2024 | 106.50 Mn |
| Jun 30, 2024 | 106.60 Mn |
| Mar 31, 2024 | 300,000.00 |
| Dec 31, 2023 | 224.10 Mn |
| Sep 30, 2023 | 11.70 Mn |
| Jun 30, 2023 | 250.90 Mn |
| Mar 31, 2023 | 610,000.00 |
| Dec 31, 2022 | 600,000.00 |
| Sep 30, 2022 | 4.80 Mn |
| Jun 30, 2022 | 223.50 Mn |
| Mar 31, 2022 | 7.05 Mn |
| Dec 31, 2021 | 4.95 Mn |
| Sep 30, 2021 | 5.01 Mn |
| Jun 30, 2021 | 5.32 Mn |